Palisade Capital Management’s Emergent Biosolutions EBS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.97M	Sell	1,201,323 -64,443	-5%	-$667K	0.33%	96
2025 Q4	$15.6M	Sell	1,265,766 -160,253	-11%	-$1.72M	0.46%	80
2025 Q3	$12.6M	Buy	1,426,019 +326,260	+30%	+$2.54M	0.34%	97
2025 Q2	$7.02M	Sell	1,099,759 -41,830	-4%	-$239K	0.2%	134
2025 Q1	$5.55M	Buy	1,141,589 +202,857	+22%	+$1.68M	0.16%	155
2024 Q4	$8.97M	Buy	938,732 +188,802	+25%	+$1.73M	0.24%	116
2024 Q3	$6.26M	Buy	749,930 +296,101	+65%	+$2.69M	0.17%	145
2024 Q2	$3.1M	Sell	453,829 -7,819	-2%	-$33.6K	0.08%	205
2024 Q1	$1.17M	Buy	461,648 +11,236	+2%	+$25.3K	0.03%	279
2023 Q4	$1.08M	Sell	450,412 -58,913	-12%	-$138K	0.03%	298
2023 Q3	$1.73M	Sell	509,325 -29,093	-5%	-$161K	0.05%	245
2023 Q2	$3.96M	Buy	538,418 +24,547	+5%	+$228K	0.11%	185
2023 Q1	$5.32M	Buy	513,871 +12,199	+2%	+$147K	0.14%	166
2022 Q4	$5.92M	Sell	501,672 -25,317	-5%	-$392K	0.16%	166
2022 Q3	$11.1M	Sell	526,989 -39,091	-7%	-$1.09M	0.31%	105
2022 Q2	$17.6M	Buy	566,080 +5,671	+1%	+$194K	0.48%	71
2022 Q1	$23M	Sell	560,409 -24,548	-4%	-$1.08M	0.53%	66
2021 Q4	$25.4M	Sell	584,957 -58,507	-9%	-$2.65M	0.51%	69
2021 Q3	$32.2M	Buy	643,464 +40,984	+7%	+$2.48M	0.7%	42
2021 Q2	$38M	Sell	602,480 -23,489	-4%	-$1.51M	0.86%	25
2021 Q1	$58.2M	Buy	625,969 +46,960	+8%	+$4.81M	1.37%	5
2020 Q4	$51.9M	Buy	579,009 +150,134	+35%	+$13.8M	1.33%	5
2020 Q3	$44.3M	Buy	428,875 +58,825	+16%	+$6.34M	1.34%	6
2020 Q2	$29.3M	Buy	370,050 +169,448	+84%	+$12.6M	0.93%	14
2020 Q1	$11.6M	Buy	200,602 +75,686	+61%	+$4.36M	0.43%	80
2019 Q4	$6.74M	Buy	+124,916	New	+$6.78M	0.19%	152
2016 Q3	–	Sell	-7,155	Closed	-$201K	–	568
2016 Q2	$201K	Buy	+7,155	New	+$281K	0.01%	518